• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性全身炎症期间诱导血管性血友病因子释放后ADAMTS13(血管性血友病因子裂解蛋白酶)活性的变化。

Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.

作者信息

Reiter Rosemarie A, Varadi Katalin, Turecek Peter L, Jilma Bernd, Knöbl Paul

机构信息

Department of Clinical Pharmacology, Medical University of Vienna, Austria.

出版信息

Thromb Haemost. 2005 Mar;93(3):554-8. doi: 10.1160/TH04-08-0467.

DOI:10.1160/TH04-08-0467
PMID:15735809
Abstract

Von Willebrand factor (VWF) is synthesized in endothelial cells, stored in the form of high molecular weight multimers and released after stimulation. After release, the multimers are cleaved by ADAMTS13 (von-Willebrand-factor-cleaving protease). We studied healthy volunteers in a double-blind, placebo controlled inflammation model. Ten male volunteers received 2 ng/kg endotoxin intravenously, and 5 volunteers placebo. Endotoxin infusion induced systemic inflammation and coagulation activation. After 4 hours the observed increase in neutrophils reached a maximum (273+/-34% of baseline; mean+/-SEM) and the platelet count dropped (81+/-2%). These parameters returned to baseline values after 24 hours. VWF antigen increased to 259+/-16% of baseline after 4 hours, remained elevated (192+/-15%) after 24 hours and returned to baseline after 7 days. Unusually large VWF multimers occurred in the plasma 4 hours after endotoxin infusion. ADAMTS13 activity (measured with a collagen-binding assay) decreased to 64+/-5% of baseline (P<0.001) after 4 hours, was still reduced after 24 hours (86+/- %; P=0.008) and returned to normal after 7 days. VWF multimer analysis showed pronounced satellite bands in the 4-hour samples, indicating cleavage of VWF by ADAMTS13. No apparent changes of the analyzed parameters were observed in the placebo group. The reciprocal course of ADAMTS13 and VWF after short-term VWF release induced by systemic inflammation is similar to that observed after induction of VWF release by desmopressin.

摘要

血管性血友病因子(VWF)在内皮细胞中合成,以高分子量多聚体的形式储存,并在受到刺激后释放。释放后,这些多聚体被ADAMTS13(血管性血友病因子裂解蛋白酶)裂解。我们在一个双盲、安慰剂对照的炎症模型中研究了健康志愿者。10名男性志愿者静脉注射2 ng/kg内毒素,5名志愿者注射安慰剂。内毒素输注引发全身炎症和凝血激活。4小时后,观察到的中性粒细胞增加达到最大值(为基线的273±34%;平均值±标准误),血小板计数下降(81±2%)。这些参数在24小时后恢复到基线值。VWF抗原在4小时后增加到基线的259±16%,24小时后仍保持升高(192±15%),并在7天后恢复到基线。内毒素输注4小时后,血浆中出现异常大的VWF多聚体。4小时后,ADAMTS13活性(用胶原结合试验测量)降至基线的64±5%(P<0.001),24小时后仍降低(86±%;P=0.008),并在7天后恢复正常。VWF多聚体分析显示4小时样本中有明显的卫星带,表明ADAMTS13对VWF进行了裂解。在安慰剂组中未观察到分析参数的明显变化。全身炎症诱导的VWF短期释放后,ADAMTS13和VWF的相反变化过程与去氨加压素诱导VWF释放后观察到的相似。

相似文献

1
Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.急性全身炎症期间诱导血管性血友病因子释放后ADAMTS13(血管性血友病因子裂解蛋白酶)活性的变化。
Thromb Haemost. 2005 Mar;93(3):554-8. doi: 10.1160/TH04-08-0467.
2
Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.去氨加压素输注后血管性血友病因子裂解蛋白酶(ADAMTS13)活性的变化
Blood. 2003 Feb 1;101(3):946-8. doi: 10.1182/blood-2002-03-0814. Epub 2002 Sep 19.
3
Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis.在晚期肝硬化基础上发生全身炎症时血管性血友病因子及其裂解蛋白酶ADAMTS13的失衡
Liver Int. 2015 Jan;35(1):37-45. doi: 10.1111/liv.12657. Epub 2014 Sep 3.
4
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.子痫前期患者血浆血管性血友病因子抗原水平升高,但血管性血友病因子裂解蛋白酶(ADAMTS13)活性正常。
Thromb Haemost. 2009 Feb;101(2):305-11.
5
Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.急性心肌梗死后血管性血友病因子裂解蛋白酶(ADAMTS13)的系列变化与预后
Am J Cardiol. 2007 Sep 1;100(5):758-63. doi: 10.1016/j.amjcard.2007.03.095. Epub 2007 Jun 12.
6
Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.中性粒细胞蛋白酶在肾小球中对血管性血友病因子的切割 - 肾脏中的一种抗血栓机制。
EBioMedicine. 2017 Feb;16:302-311. doi: 10.1016/j.ebiom.2017.01.032. Epub 2017 Jan 24.
7
C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.C2362F 突变导致 ADAMTS13 抵抗的血管性血友病因子。
Thromb Haemost. 2013 Jun;109(6):999-1006. doi: 10.1160/TH12-11-0808. Epub 2013 Feb 28.
8
ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition.ADAMTS13 活性在脓毒症猪模型中降低。对肾小球血栓沉积的意义。
Thromb Haemost. 2011 Jan;105(1):145-53. doi: 10.1160/TH10-03-0153. Epub 2010 Nov 5.
9
Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.慢性肾病患者血浆血管性血友病因子水平及血管性血友病因子裂解蛋白酶活性的意义
Chin Med J (Engl). 2008 Jan 20;121(2):133-6.
10
Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.慢性冠心病中血管性血友病因子水平的升高是由血管性血友病因子裂解蛋白酶活性降低所致吗?一项使用针对血管性血友病因子蛋白完整842Tyr-843Met键的抗体进行免疫测定的研究。
Thromb Res. 2001 Aug 1;103(3):241-8. doi: 10.1016/s0049-3848(01)00320-6.

引用本文的文献

1
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction.血管性血友病因子、含血小板解聚蛋白基元的金属蛋白酶13及血小板反应蛋白1与近期发生心肌梗死的老年患者临床结局的关系
Res Pract Thromb Haemost. 2023 Apr 23;7(4):100164. doi: 10.1016/j.rpth.2023.100164. eCollection 2023 May.
2
The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study.凝血因子对子宫内膜异位症风险的影响:一项孟德尔随机化研究。
BMC Med. 2023 May 25;21(1):195. doi: 10.1186/s12916-023-02881-z.
3
The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure.
血管性血友病因子抗原与ADAMTS13活性比值:作为慢加急性肝衰竭预后生物标志物的效用
Biology (Basel). 2023 Jan 20;12(2):164. doi: 10.3390/biology12020164.
4
Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty.择期关节置换术患者血浆中ADAMTS13和血管性血友病因子水平的变化
J Clin Med. 2022 Oct 30;11(21):6436. doi: 10.3390/jcm11216436.
5
Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis.可溶性甘露糖受体CD206和血管性血友病因子是用于识别重症或坏死性急性胰腺炎高危患者的早期生物标志物。
J Intensive Care. 2022 Jun 11;10(1):28. doi: 10.1186/s40560-022-00619-2.
6
ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability.ADAMTS13、血管性血友病因子(VWF)和内毒素相互关联,并通过高凝状态与肝硬化的严重程度相关。
J Clin Med. 2022 Mar 26;11(7):1835. doi: 10.3390/jcm11071835.
7
Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.脓毒症和非脓毒症 ICU 患者 ADAMTS13 和血管性血友病因子水平的特征。
PLoS One. 2021 Feb 19;16(2):e0247017. doi: 10.1371/journal.pone.0247017. eCollection 2021.
8
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.严重 COVID-19 感染导致的凝血功能障碍和血栓形成:微血管焦点。
Thromb Haemost. 2020 Dec;120(12):1668-1679. doi: 10.1055/s-0040-1715841. Epub 2020 Aug 24.
9
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin.适体 BT200 可有效抑制血管性血友病因子(VWF)依赖性血小板功能,在去氨加压素或内毒素刺激 VWF 释放后。
Sci Rep. 2020 Jul 7;10(1):11180. doi: 10.1038/s41598-020-68125-9.
10
Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques.动脉粥样硬化血栓形成的病理生理学:破裂粥样硬化斑块上血栓形成的机制。
Pathol Int. 2020 Jun;70(6):309-322. doi: 10.1111/pin.12921. Epub 2020 Mar 13.